| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
39 |
| Employees |
6,395 |
| Revenues (TTM) (Millions $) |
442 |
| Net Income (TTM) (Millions $) |
57 |
| Cash Flow (TTM) (Millions $) |
10 |
| Capital Exp. (TTM) (Millions $) |
19 |
Business Description
Genomic Health Inc. is a precision medicine company that specializes in cancer diagnostics. It was founded in 2000 and is based in Redwood City, California. The company is dedicated to transforming cancer care through the development and commercialization of molecular diagnostic tests that provide physicians with a personalized approach to treating cancer patients.
Genomic Health's innovative tests use advanced genomic technology to analyze a patient's tumor to predict disease aggressiveness, response to treatment, and likelihood of recurrence. These tests help oncologists make more informed treatment decisions and provide patients with a more personalized approach to cancer care.
The company's flagship product is the Oncotype DX test, which is used to determine the likelihood of breast cancer recurrence and the benefit of chemotherapy after surgery. Oncotype DX analyzes the expression of 21 genes in a patient's tumor sample and generates a score that predicts the risk of recurrence. This test has been used to guide treatment decisions for over a million breast cancer patients worldwide.
In addition to the Oncotype DX test, Genomic Health has developed other diagnostic tests for prostate, colon, and lung cancers. The company is also developing new diagnostic products for other cancers, including melanoma, bladder cancer, and pancreatic cancer.
Genomic Health is committed to ensuring that its tests are accessible to all patients who need them. The company works closely with insurers, government agencies, and patient advocacy groups to ensure that its tests are covered by insurance and reimbursed at fair prices. Genomic Health also offers financial assistance programs to help low-income patients access its tests.
In 2019, Genomic Health was acquired by Exact Sciences, a leading precision oncology company. The two companies continue to work together to advance cancer diagnostics and treatment.
Company Address: 301 Penobscot Drive Redwood City 94063 CA
Company Phone Number: 556-9300 Stock Exchange / Ticker: NASDAQ GHDX
|
%